Single-cell profiling exposes fibrotic and immune cell diversity in urethral stricture
Urethral stricture remains a stubborn reconstructive problem because the scar itself behaves like a living tissue, not a static lesion. In this single-cell RNA sequencing study, investigators profiled three urethral scar samples and three paired normal urethral tissues to separate the cellular architecture of stenosis from that of uninvolved tissue. The central finding was not simply that scar tissue contained more fibrosis-related cells. It was that fibroblasts, mast cells, and macrophages were each split into distinct subclusters with their own transcriptional signatures, suggesting that urethral scarring is driven by a layered immune-stromal program rather than a uniform expansion of one cell type.
Eight major cell types were detected across the dataset. Among them, fibroblasts, mast cells, and macrophages accounted for the most consequential shifts in scar tissue. Fibroblasts were divided into seven subclusters, mast cells into two, and macrophages into nine, a degree of granularity that matters because fibrosis is rarely orchestrated by one fibroblast state alone. Instead, the scar niche appears to recruit several mesenchymal and immune programs at once, each likely contributing different pieces of the extracellular matrix response, inflammatory signaling, and tissue remodeling cycle.
Fibroblast, mast cell, and macrophage subclusters track with extracellular matrix remodeling
A sharp enrichment of FB3 fibroblasts, Mast1 mast cells, and Macro1 and Macro7 macrophages appeared in urethral scar tissue. Their marker genes mapped to fibrosis-linked biology, including cell adhesion and extracellular matrix organization. In practical terms, this is the molecular language of scar persistence: cells that adhere more readily, migrate differently, or deposit matrix more aggressively can lock the urethral wall into a narrowed, fibrotic state. Once that architecture matures, normal urine flow becomes mechanically constrained and the chance of recurrent stenosis rises.
The cellular split is especially relevant for fibroblasts, because urethral fibrosis is not just a matter of more fibroblasts; it is a matter of which fibroblast programs dominate. The FB3 subset emerged as a candidate fibrogenic population, and its regulatory profile pointed toward ETS1 as a candidate transcription factor. ETS1 has been linked in other fibrotic contexts to cell activation, migration, and matrix-related gene expression, making its appearance in this urethral scar atlas biologically plausible rather than incidental. A single driver rarely explains fibrosis, but a transcriptional regulator that coordinates adhesive and matrix programs can help stabilize the scar phenotype.
The mast cell compartment deserves equal attention. Mast cells are often discussed as inflammatory amplifiers, yet they can act as stromal tutors in fibrotic disease by releasing mediators that influence fibroblast activation and matrix turnover. Here, Mast1 showed a regulatory pattern centered on SMAD3, a canonical signaling node in pro-fibrotic pathways. In a tissue where the scar narrows the lumen, mast-cell-derived signaling may help sustain a local environment favorable to collagen deposition and prolonged wound remodeling.
Candidate regulators point to coordinated profibrotic signaling
The transcription factor analysis and metabolic profiling together suggest that urethral stricture is maintained by coordinated changes in gene regulation rather than isolated cell activation. Alongside ETS1 in FB3 and SMAD3 in Mast1, the study identified dysregulated transcriptional and metabolic pathways within the fibrotic niche. Those signals matter because fibrosis depends on more than extracellular matrix production; it also depends on the energy state of the cells building the matrix, the stress responses sustaining them, and the communication pathways that reinforce their behavior.
Metabolic reprogramming was assessed to capture that hidden layer of biology. Scar-forming cells do not operate with the same energetic demands as quiescent tissue cells. A fibroblast that is actively remodeling matrix, or a macrophage that is sustaining inflammatory and reparative signaling, needs a metabolic program that can support biosynthesis, survival, and intercellular signaling. The study’s metabolic analysis therefore adds a useful dimension: the scar is not just transcriptionally active, it is metabolically organized to support persistent remodeling.
Fibroblast-macrophage communication intensifies inside the scar niche
CellChat analysis showed substantially increased communication between fibroblasts and other cell types in scar tissue, along with stronger interactions involving Macro1 and Macro7 and other macrophage subclusters or fibroblasts. This is the part of the dataset that best explains why the lesion can become self-reinforcing. Fibroblasts can recruit or condition immune cells, while macrophages can return signals that activate fibroblasts further, creating a loop that favors persistence over resolution.
This crosstalk is clinically relevant because urethral stricture recurrence remains a major problem even after technically successful surgery. Surgery restores anatomy, but it does not necessarily reset the local cellular network that built the scar in the first place. If fibroblast subsets and macrophage states continue to communicate after repair, the tissue may remain biased toward renewed fibrosis. The same logic applies to mast cells, which may help amplify this milieu through paracrine signaling. The result is a scar niche that behaves less like a passive remnant and more like an active tissue ecosystem.
Validation work strengthened the sequencing findings. Immunofluorescence and toluidine blue staining were used in additional patient tissues to assess markers linked to fibroblasts, mast cells, and macrophages, supporting the presence of the identified cellular populations in scarred urethra. Those tissue-level assays do not solve causality, but they anchor the transcriptomic map in histologic reality.
For urologic practice, the value of this atlas lies in target generation. Urethral stricture still lacks a drug-based method to reverse fibrosis, so any credible map of the scar microenvironment is useful if it identifies tractable regulators or communication nodes. ETS1, SMAD3, and the macrophage-fibroblast interaction network now stand out as candidate routes for future mechanistic work. Before any therapeutic translation, though, the biology needs broader validation in larger cohorts and across stricture etiologies, because this dataset came from only three patients with trauma-related disease and paired normal tissue. The atlas is informative, but it is not yet a treatment blueprint.